Cognetivity Neurosciences Ltd
Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Co… Read more
Cognetivity Neurosciences Ltd (CGNSF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of October 2023: -0.001x
Based on the latest financial reports, Cognetivity Neurosciences Ltd (CGNSF) has a cash flow conversion efficiency ratio of -0.001x as of October 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($16.93K) by net assets ($-15.20 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cognetivity Neurosciences Ltd - Cash Flow Conversion Efficiency Trend (2016–2023)
This chart illustrates how Cognetivity Neurosciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Cognetivity Neurosciences Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cognetivity Neurosciences Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
We Can Medicines Co., Ltd.
TWO:6929
|
N/A |
|
Future Generation Global Ltd
AU:FGG
|
0.073x |
|
SCIENT DIGIT IMAG
BE:SD0
|
N/A |
|
Pengana Private Equity Trust
AU:PE1
|
0.006x |
|
Fine Besteel Co. Ltd.
KQ:133820
|
N/A |
|
BioLASCO Taiwan Co., Ltd.
TWO:6662
|
N/A |
|
MATD3F
SA:MATD3F
|
N/A |
|
Watkin Jones PLC
LSE:WJG
|
-0.062x |
Annual Cash Flow Conversion Efficiency for Cognetivity Neurosciences Ltd (2016–2023)
The table below shows the annual cash flow conversion efficiency of Cognetivity Neurosciences Ltd from 2016 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-01-31 | $-9.89 Million | $-5.94 Million | 0.601x | +6.09% |
| 2022-01-31 | $-5.68 Million | $-3.21 Million | 0.566x | +124.95% |
| 2021-01-31 | $862.91K | $-1.96 Million | -2.270x | -132.16% |
| 2020-01-31 | $-263.04K | $-1.86 Million | 7.058x | +196.98% |
| 2019-01-31 | $479.41K | $-3.49 Million | -7.278x | -2768.46% |
| 2018-01-31 | $3.39 Million | $-859.73K | -0.254x | -107.73% |
| 2017-01-31 | $-99.43K | $-326.18K | 3.281x | +214431.01% |
| 2016-01-31 | $-122.52K | $187.53 | -0.002x | -- |